Injective Surges 6.5% on ETF Rumors, Supply Squeeze | Top Stories | CoinMarketCap
Injective (INJ) climbed 6.5% to $8.18 on ETF rumors and deflationary tokenomics. CEO expects US ETFs before 2027, boosting institutional adoption narrative.

What's Your Reaction?









